Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.
Read original at benzingaStocks · News reference
Neogen Sees Q1 Sales $207.000M-$209.000M vs $204.710M Est
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 30, 2026, 11:03 AM
- Checked
- Jul 30, 2026, 11:03 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — NEOGEN CORP (NEOG)
Filed: 2026-08-07 AccNo: 0001193125-26-340216 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarPiper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13
Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.
Read original at benzingaNeogen shares are trading higher after the company reported better-than-expected Q4 financial results.
Read original at benzinga